HRES 928 · 119th CongressIn Committeecongress.gov ↗

Affirming support for most-favored-Nation drug pricing for United States patients.

What this bill does

AI plain-language summary

This bill appears to support giving United States patients access to drug pricing that matches the best prices other countries receive, known as "most-favored-nation" pricing. No official summary is available for this bill.

Introduced

December 4, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.